Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX) will divest its tumour radiation equipment (HDR) business. As a first step, it has sold 51% of the shares in BEBIG Medical GmbH, into which it had transferred the HDR […]
Author: Firma Eckert & Ziegler Strahlen- und Medizintechnik
Eckert & Ziegler to Start Development of Radioisotope Production Facility in Jintan, PR China
Posted on Posted in General
Eckert & Ziegler (ISIN DE0005659700), a global specialist for radioactive medical and industrial applications based in Berlin, Germany, has signed an investment agreement with the Administrative Committee of Jiangsu Jintan Economic Development Zone (PR China) for the acquisition and commercial […]
Eckert & Ziegler Wins Order for Hot Cell Construction from Dutch Research Center
Posted on Posted in General
Eckert & Ziegler has been awarded a contract to build hot cells with a value of several million euros. The order was placed by the Nuclear Research and Consultancy Group (NRG) in Petten (NL), a global market leader in producing […]
Eckert & Ziegler to Build cGMP Facility for Radiopharmaceutical Services in USA
Posted on Posted in General
Eckert & Ziegler is proud to announce that it is expanding its production site in Wilmington just north of Boston, Massachusetts of a new production facility for the contract manufacturing of radiopharmaceuticals. This new cGMP clean room suite will be […]
Eckert & Ziegler: Seed Implantation for Prostate Cancer Receives Reimbursement for Outpatient Care
Posted on Posted in General
Seed implantation for prostate cancer is now to be reimbursed as an outpatient treatment by public health insurances in Germany. This was decided by the Federal Joint Committee (G-BA) with effect from January 8, 2021. Seed implantation or so called […]
Nine-Month Figures Eckert & Ziegler: Growth in Radiopharmaceuticals Compensates for Corona Losses
Posted on Posted in General
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, again achieved a very strong result of EUR 17.7 million in the first nine months of 2020. Compared to the […]
Eckert & Ziegler Records Solid Half-Year Results
Posted on Posted in General
Despite heavy burdens from corona and the drop in oil price, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700, TecDAX), a specialist for isotope applications in medicine, science and industry, closed the first half of 2020 with a net […]
Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020
Posted on Posted in General
Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) announces that the increase in share capital approved by the Annual General Meeting on 10 June 2020 has been registered in the commercial register and that the share split can now be implemented. […]
Eckert & Ziegler Increases Profit Forecast to 4 Euro per Share
Posted on Posted in General
Based on initial, un-audited assessments, revenues and earnings of Berlin-based isotope specialists Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) for the half year ending 30 June 2020 are significantly higher than expected. The consolidated result in the first […]